You just read:

Aldeyra Therapeutics Announces Results from Allergic Conjunctivitis Phase 2b Clinical Trial and Plans for Phase 3 Clinical Testing

News provided by

Aldeyra Therapeutics, Inc.

Jun 14, 2017, 06:50 ET